

MDS Podcast
International Parkinson and Movement Disorder Society
Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders. Each episode of the International Parkinson and Movement Disorder Society podcast discusses a relevant development in the field, including highlighted journal articles and interviews with the authors.
Episodes
Mentioned books

Nov 16, 2026 • 0sec
MDCP Research Article of the Year: Early Motor Signs in Pathologically Verified Alzheimer's Disease and Lewy Body Disease
Dr. Eduardo de Pablo-Fernández discusses with Dr. Daniel Oh findings from an award-winning MDCP study identifying early motor signs, particularly hypomimia, that may help distinguish Alzheimer’s disease with Lewy body co-pathology from Alzheimer’s disease alone.
Read the article.

Nov 16, 2026 • 0sec
MDCP Review Article of the Year: Pregnancy and Parkinson’s disease: Navigating care before, during, and after
In this episode, Dr. Alexander Lehn discusses the MDCP Review Article of the Year, exploring the clinical management of Parkinson’s disease across the reproductive journey: before conception, during pregnancy, and in the postpartum period. He shares the current evidence, practical challenges, medication safety considerations, and multidisciplinary decision-making. The conversation highlights gaps in data, real-world clinical strategies, and key counseling points to support optimal outcomes for both the parent and child.
Read the article.

Nov 9, 2026 • 0sec
MDJ Research Article of the Year: Cognitive Phenotyping Via Digital Analysis of Spoken Word Properties
In this episode, Dr. Michele Matarazzo interviews Dr. Adolfo M. García, senior author of the MDJ Research Article of the Year in Movement Disorders. They discuss how automated analysis of verbal fluency tasks in 464 Spanish-speaking people with Parkinson's disease can predict global cognition and identify mild cognitive impairment more accurately than simple word counts, as well as the potential for brief, scalable digital cognitive assessments.
Read the article.

Nov 9, 2026 • 0sec
MDJ Review Article of the Year: Beyond Go and No-Go: Rethinking the Basal Ganglia
The classic direct and indirect pathways of the basal ganglia are often taught as simple “Go” and “No-Go” systems for movement. But emerging evidence reveals a much richer picture. Dr. Michele Matarazzo speaks with Dr. Ann Graybiel about her 2026 Review Article of the Year Paper in Movement Disorders, exploring how basal ganglia circuits contribute to learning, decision-making, motivation, and mood; the emerging role of the external globus pallidus; and newly identified striosomal pathways that regulate dopamine and may reshape our understanding of Parkinson’s disease and other movement disorders.
Read the article.

Nov 2, 2026 • 0sec
Hot Topic: Environmental toxicants and their role in Parkinson's disease
Dr. Ray Dorsey passionately shares the mounting evidence supporting the role environmental neuro-toxicants have in the development of Parkinson's disease (PD) and why PD prevention deserves our attention.
Read the article.

Oct 26, 2026 • 0sec
Functional Movement Disorders | Congress 2026
Ms. Nicole Duff discusses with Dr. Sara Lidstone the diagnosis and management of functional neurological and movement disorders, including clinical signs, patient-centered communication, and the importance of interdisciplinary rehabilitation.

Oct 26, 2026 • 0sec
AI and Wearable Devices: Potential and Pitfalls | Congress 2026
Dr. Mitra Afshari discusses with Dr. Jeffrey Hausdorff the potential of AI-enabled digital biomarkers in Parkinson’s disease, including their role in patient monitoring, challenges in accuracy and reliability, and barriers to clinical implementation.

Oct 21, 2026 • 0sec
Focused ultrasound | Congress 2026
Dr. Mitra Afshari discusses with Dr. Raul Martínez-Fernández recent advances in MRI-guided focused ultrasound for essential tremor and Parkinson’s disease, including improvements in safety and efficacy, its relationship with deep brain stimulation, and emerging neuromodulation approaches.

Oct 21, 2026 • 0sec
Updates in Huntington's Disease | Congress 2026
Dr. Eduardo de Pablo-Fernández discusses with Dr. Samuel Kim recent advances in Huntington’s disease, including genetic mechanisms, emerging biomarkers, and the potential of huntingtin-lowering therapies and gene therapy.

Oct 19, 2026 • 0sec
Update on disease modifying trials for Parkinson’s disease | Congress 2026
Dr. Eduardo de Pablo-Fernández discusses with Prof. Tom Foltynie emerging disease-modifying and restorative treatments for Parkinson’s disease, including recent clinical trial findings and promising therapeutic approaches.


